1 January 2015 in Annals of Transplantation
After introduction of MELD-based allocation in Germany, decreased waiting list mortality and increased mortality after transplantation have been reported.
1 December 2006 in Liver Transplantation
In fulminant hepatic failure, the use of bioartificial liver support (BAL) with porcine hepatocytes is the subject of a current and controversial debate.1 Specifically, the issue of cross‐species physiological incompatibilities has not been addressed so far. We therefore investigated the effects of species‐specific cytokines in single and cocultures on hepatocyte function. Hepatocyte cultures were isolated from human resection specimens and from Landrace pigs. Single and cocultures were exposed to porcine and human interleukin (IL)‐6 or tumor necrosis factor (TNF)‐α. Changes in expression of C‐reactive protein (CRP), albumin, CCAAT enhancer binding protein (C/EBP)‐α and C/EBP‐β and metabolic competence of cultured cells was studied by measuring testosterone metabolite production. After human or porcine IL‐6 dosing, CRP was induced up to 100‐fold in human hepatocyte cultures, while porcine hepatocytes responded marginally (2‐ to 5‐fold). Treatment with human or porcine IL‐6 or TNF‐α resulted in reduced albumin production, albeit at different levels when human and porcine hepatocytes were compared (P = 0.001). Unlike human, porcine hepatocytes produced less of 6α‐hydroxytestosterone (6α‐HT) (P < 0.001) and 7α‐HT (P < 0.001) after human or porcine IL‐6 dosing and treatment with species‐specific TNF‐α induced (human hepatocytes) or decreased (porcine hepatocytes) 6β‐HT production (P = 0.021). In coculture with free exchange of metabolites, porcine hepatocytes produced less 6α‐HT (P = 0.048) and 16α‐HT (P = 0.033), whereas after treatment with human IL‐6 reduced CRP gene and protein expression was observed with human hepatocytes (P = 0.013). In conclusion, species‐specific responses of hepatocytes to cytokines and interactions with xenobiotic metabolites may limit the clinical effectiveness of porcine hepatocytes in BAL. Liver Transpl 12:1832–1840, 2006. © 2006 AASLD.
1 January 2015 in Annals of Transplantation
BACKGROUND The model of end-stage liver disease (MELD) score is currently used for donor liver allocation in many regions. The objective of this retrospective study was to assess the MELD score and its diverse variants as prognostic models for mortality after liver transplantation. MATERIAL AND METHODS An analysis of 454 consecutive adult liver transplants since the introduction of MELD-based donor liver allocation was conducted. Eight different MELD score variants were investigated. Receiver operating characteristic (ROC) curve analysis was performed to calculate the sensitivity, specificity, and overall model correctness of the investigated scores as a predictive model. The Brier score was used for the prediction of model accuracy and calculated as described before. Study endpoints were 90-day mortality and long-term patient mortality. RESULTS A 90-day mortality of 15.4% (n=69) and long-term mortality of 25% (n=112) were observed. All investigated models fail to reach relevant areas under the ROC curve greater than 0.700 for the prediction of mortality after liver transplantation. All calculated Brier scores were greater than 0.25, indicating a significant lack of model discrimination and calibration of the investigated scores. CONCLUSIONS A prognostic model for the prediction of outcome after transplantation still needs to be identified and should allow weighing urgency against utility in liver transplantation.
18 October 2016 in Hepatology Research
1 February 2017 in Journal of Clinical and Experimental Hepatology